06/17/2025
4:28 PM | Point72 Asset Management, L.P. (Filed by)
Xilio Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/12/2025
3:55 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Xilio Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/12/2025
3:30 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2025
3:33 PM | Bello Akintunde Olatokumbo (Reporting)
Xilio Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/12/2025
3:34 PM | Bello Akintunde Olatokumbo (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:34 PM | Rossi Christina (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:35 PM | Shannon James Samuel (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:35 PM | Xilio Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:36 PM | Clancy Paul J (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:36 PM | Curran Daniel J. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:36 PM | Bonstein Sara (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for XLO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/10/2025
3:35 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
6:31 PM | GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
6:38 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
6:43 AM | Xilio Therapeutics (Filer)
| Form DEFA14A | |
06/03/2025
6:31 AM | Xilio Therapeutics (Filer)
| Form 424B5 | |
06/02/2025
5:48 AM | Xilio Therapeutics (Filer)
| Form 424B5 | |
06/02/2025
5:08 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
9:48 AM | Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
11:15 PM | Xilio Therapeutics (Filer)
| Form EFFECT | |
05/08/2025
3:31 PM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:35 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
3:32 PM | Xilio Therapeutics (Filer)
| Form S-3/A | |
04/28/2025
3:30 PM | Xilio Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
3:32 PM | Xilio Therapeutics (Filer)
| Form DEFA14A | |
04/28/2025
3:33 PM | Xilio Therapeutics (Filer)
| Form ARS | |
04/18/2025
8:30 AM | Xilio Therapeutics (Filer)
| Form PRE 14A | |
04/16/2025
3:30 PM | Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
3:30 PM | Russo Rene (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
8:30 AM | Xilio Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/11/2025
7:50 AM | Xilio Therapeutics (Filer)
| Form 424B5 | |
03/11/2025
7:54 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
7:43 AM | Xilio Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2025
7:15 AM | Xilio Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2025
6:39 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
6:36 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
4:09 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
3:15 PM | GILEAD SCIENCES, INC. (Filed by)
Xilio Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/19/2024
3:19 PM | GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
6:45 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:44 PM | Bain Capital Life Sciences Fund II, L.P. (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
11/12/2024
3:50 PM | Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
9:40 AM | FMR LLC (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
8:25 AM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
8:20 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
8:36 PM | GKCC, LLC (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G | |
09/27/2024
8:00 PM | Chudnovsky Yekaterina (Reporting)
GKCC, LLC (Reporting)
Xilio Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/08/2024
6:45 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:51 AM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
7:00 PM | Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
6:46 AM | TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
